Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Drugs Approved for Malignant Mesothelioma

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for malignant mesothelioma. The list includes generic names and brand names. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in malignant mesothelioma that are not listed here.

Drugs Approved for Malignant Mesothelioma

Alimta (Pemetrexed Disodium)
Ipilimumab
Nivolumab
Opdivo (Nivolumab)
Pemetrexed Disodium
Yervoy (Ipilimumab)

Drug Combinations Used in Malignant Mesothelioma

GEMCITABINE-CISPLATIN